| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 7.00e-12 | 4 | 34 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 7.00e-12 | 4 | 34 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 3.50e-11 | 5 | 34 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 2.44e-10 | 7 | 34 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 8.77e-10 | 9 | 34 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.46e-09 | 10 | 34 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.95e-09 | 13 | 34 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.56e-07 | 74 | 34 | 5 | GO:0016782 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 2.25e-06 | 55 | 34 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | D-ribulose-phosphate 3-epimerase activity | 2.81e-06 | 2 | 34 | 2 | GO:0004750 | |
| GeneOntologyMolecularFunction | choline kinase activity | 8.43e-06 | 3 | 34 | 2 | GO:0004103 | |
| GeneOntologyMolecularFunction | ethanolamine kinase activity | 1.68e-05 | 4 | 34 | 2 | GO:0004305 | |
| GeneOntologyMolecularFunction | disaccharide binding | 5.88e-05 | 7 | 34 | 2 | GO:0048030 | |
| GeneOntologyMolecularFunction | galactoside binding | 1.01e-04 | 9 | 34 | 2 | GO:0016936 | |
| GeneOntologyMolecularFunction | racemase and epimerase activity, acting on carbohydrates and derivatives | 1.53e-04 | 11 | 34 | 2 | GO:0016857 | |
| GeneOntologyMolecularFunction | racemase and epimerase activity | 4.23e-04 | 18 | 34 | 2 | GO:0016854 | |
| GeneOntologyMolecularFunction | oligosaccharide binding | 5.25e-04 | 20 | 34 | 2 | GO:0070492 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.81e-03 | 37 | 34 | 2 | GO:0045505 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 1.83e-03 | 310 | 34 | 4 | GO:0030246 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.13e-03 | 323 | 34 | 4 | GO:1901681 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 7.79e-03 | 78 | 34 | 2 | GO:0043539 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 3.07e-11 | 5 | 34 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.31e-08 | 47 | 34 | 5 | GO:0046164 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.44e-08 | 17 | 34 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.44e-08 | 17 | 34 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.44e-08 | 17 | 34 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.85e-08 | 18 | 34 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 2.20e-08 | 52 | 34 | 5 | GO:0008210 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 5.33e-08 | 23 | 34 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | sulfation | 1.05e-07 | 27 | 34 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 1.24e-07 | 73 | 34 | 5 | GO:1901616 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 3.58e-07 | 286 | 34 | 7 | GO:0042445 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 8.06e-07 | 106 | 34 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 1.16e-06 | 13 | 34 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 1.55e-06 | 121 | 34 | 5 | GO:0006576 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 4.18e-06 | 148 | 34 | 5 | GO:0009308 | |
| GeneOntologyBiologicalProcess | response to glucocorticoid | 6.12e-06 | 160 | 34 | 5 | GO:0051384 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 6.52e-06 | 74 | 34 | 4 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 6.52e-06 | 74 | 34 | 4 | GO:0006584 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | ADCY10 SULT1A2 SULT1A4 CHKA CHKB PTEN SULT1A1 SULT1A3 RPE RPEL1 | 1.01e-05 | 1142 | 34 | 10 | GO:0019637 |
| GeneOntologyBiologicalProcess | regulation of defense response to bacterium | 1.04e-05 | 26 | 34 | 3 | GO:1900424 | |
| GeneOntologyBiologicalProcess | response to corticosteroid | 1.24e-05 | 185 | 34 | 5 | GO:0031960 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell degranulation | 1.58e-05 | 4 | 34 | 2 | GO:0043322 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 2.61e-05 | 365 | 34 | 6 | GO:0006790 | |
| GeneOntologyBiologicalProcess | pentose-phosphate shunt, non-oxidative branch | 3.94e-05 | 6 | 34 | 2 | GO:0009052 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 5.13e-05 | 412 | 34 | 6 | GO:0006066 | |
| GeneOntologyBiologicalProcess | CDP-choline pathway | 5.51e-05 | 7 | 34 | 2 | GO:0006657 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 5.63e-05 | 619 | 34 | 7 | GO:0006163 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | 5.78e-05 | 421 | 34 | 6 | GO:0044282 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell degranulation | 7.34e-05 | 8 | 34 | 2 | GO:0043321 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 7.80e-05 | 652 | 34 | 7 | GO:0072521 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 8.27e-05 | 141 | 34 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 8.50e-05 | 142 | 34 | 4 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 8.50e-05 | 142 | 34 | 4 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 8.50e-05 | 142 | 34 | 4 | GO:0034032 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 8.50e-05 | 142 | 34 | 4 | GO:0018958 | |
| GeneOntologyBiologicalProcess | regulation of hormone levels | 1.05e-04 | 684 | 34 | 7 | GO:0010817 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 1.05e-04 | 684 | 34 | 7 | GO:0009117 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 1.12e-04 | 691 | 34 | 7 | GO:0006753 | |
| GeneOntologyBiologicalProcess | phosphatidylethanolamine biosynthetic process | 1.18e-04 | 10 | 34 | 2 | GO:0006646 | |
| GeneOntologyBiologicalProcess | dopamine catabolic process | 1.18e-04 | 10 | 34 | 2 | GO:0042420 | |
| GeneOntologyBiologicalProcess | catecholamine catabolic process | 1.44e-04 | 11 | 34 | 2 | GO:0042424 | |
| GeneOntologyBiologicalProcess | catechol-containing compound catabolic process | 1.44e-04 | 11 | 34 | 2 | GO:0019614 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | 2.14e-04 | 767 | 34 | 7 | GO:0055086 | |
| GeneOntologyBiologicalProcess | phenol-containing compound catabolic process | 2.37e-04 | 14 | 34 | 2 | GO:0019336 | |
| GeneOntologyBiologicalProcess | negative regulation of CD4-positive, alpha-beta T cell proliferation | 2.73e-04 | 15 | 34 | 2 | GO:2000562 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell activation | 2.73e-04 | 15 | 34 | 2 | GO:0032815 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 3.53e-04 | 376 | 34 | 5 | GO:0008202 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte degranulation | 3.53e-04 | 17 | 34 | 2 | GO:0043301 | |
| GeneOntologyBiologicalProcess | response to steroid hormone | 3.75e-04 | 381 | 34 | 5 | GO:0048545 | |
| GeneOntologyBiologicalProcess | response to lipid | 3.91e-04 | 1126 | 34 | 8 | GO:0033993 | |
| GeneOntologyBiologicalProcess | natural killer cell degranulation | 3.97e-04 | 18 | 34 | 2 | GO:0043320 | |
| GeneOntologyBiologicalProcess | negative regulation of alpha-beta T cell proliferation | 4.43e-04 | 19 | 34 | 2 | GO:0046642 | |
| GeneOntologyBiologicalProcess | positive regulation of defense response to bacterium | 4.43e-04 | 19 | 34 | 2 | GO:1900426 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 4.70e-04 | 222 | 34 | 4 | GO:0071466 | |
| GeneOntologyBiologicalProcess | regulation of T cell chemotaxis | 4.92e-04 | 20 | 34 | 2 | GO:0010819 | |
| GeneOntologyBiologicalProcess | biogenic amine catabolic process | 4.92e-04 | 20 | 34 | 2 | GO:0042402 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell differentiation | 5.43e-04 | 21 | 34 | 2 | GO:0032823 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 5.63e-04 | 641 | 34 | 6 | GO:1901615 | |
| GeneOntologyBiologicalProcess | regulation of developmental growth | 5.91e-04 | 421 | 34 | 5 | GO:0048638 | |
| GeneOntologyBiologicalProcess | glyceraldehyde-3-phosphate metabolic process | 5.97e-04 | 22 | 34 | 2 | GO:0019682 | |
| GeneOntologyBiologicalProcess | amine catabolic process | 5.97e-04 | 22 | 34 | 2 | GO:0009310 | |
| GeneOntologyBiologicalProcess | pentose-phosphate shunt | 5.97e-04 | 22 | 34 | 2 | GO:0006098 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 7.23e-04 | 107 | 34 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | NADPH regeneration | 7.73e-04 | 25 | 34 | 2 | GO:0006740 | |
| GeneOntologyBiologicalProcess | cilium movement | 8.62e-04 | 261 | 34 | 4 | GO:0003341 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.91e-04 | 115 | 34 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | regulation of CD4-positive, alpha-beta T cell proliferation | 9.71e-04 | 28 | 34 | 2 | GO:2000561 | |
| GeneOntologyBiologicalProcess | positive regulation of interleukin-6 production | 1.06e-03 | 122 | 34 | 3 | GO:0032755 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 1.11e-03 | 124 | 34 | 3 | GO:0050672 | |
| GeneOntologyBiologicalProcess | phosphatidylcholine biosynthetic process | 1.11e-03 | 30 | 34 | 2 | GO:0006656 | |
| GeneOntologyBiologicalProcess | phosphatidylethanolamine metabolic process | 1.11e-03 | 30 | 34 | 2 | GO:0046337 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell proliferation | 1.11e-03 | 30 | 34 | 2 | GO:0035739 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 1.16e-03 | 126 | 34 | 3 | GO:0032945 | |
| GeneOntologyBiologicalProcess | neuron projection organization | 1.19e-03 | 127 | 34 | 3 | GO:0106027 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte chemotaxis | 1.19e-03 | 31 | 34 | 2 | GO:1901623 | |
| GeneOntologyBiologicalProcess | positive regulation of regulatory T cell differentiation | 1.19e-03 | 31 | 34 | 2 | GO:0045591 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac muscle cell apoptotic process | 1.27e-03 | 32 | 34 | 2 | GO:0010666 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 1.27e-03 | 32 | 34 | 2 | GO:1903306 | |
| GeneOntologyBiologicalProcess | glucose 6-phosphate metabolic process | 1.27e-03 | 32 | 34 | 2 | GO:0051156 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle cell apoptotic process | 1.35e-03 | 33 | 34 | 2 | GO:0010663 | |
| GeneOntologyBiologicalProcess | T cell chemotaxis | 1.35e-03 | 33 | 34 | 2 | GO:0010818 | |
| GeneOntologyBiologicalProcess | axon ensheathment in central nervous system | 1.35e-03 | 33 | 34 | 2 | GO:0032291 | |
| GeneOntologyBiologicalProcess | central nervous system myelination | 1.35e-03 | 33 | 34 | 2 | GO:0022010 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor production | 1.36e-03 | 133 | 34 | 3 | GO:0032760 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 1.38e-03 | 134 | 34 | 3 | GO:0070664 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 1.42e-03 | 512 | 34 | 5 | GO:0009150 | |
| GeneOntologyBiologicalProcess | positive regulation of tumor necrosis factor superfamily cytokine production | 1.48e-03 | 137 | 34 | 3 | GO:1903557 | |
| GeneOntologyBiologicalProcess | organic acid metabolic process | 1.51e-03 | 1064 | 34 | 7 | GO:0006082 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 1.69e-03 | 533 | 34 | 5 | GO:0009259 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation in thymus | 1.69e-03 | 37 | 34 | 2 | GO:0033081 | |
| GeneOntologyBiologicalProcess | natural killer cell differentiation | 1.79e-03 | 38 | 34 | 2 | GO:0001779 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 1.79e-03 | 540 | 34 | 5 | GO:0019693 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | 1.90e-03 | 811 | 34 | 6 | GO:0016567 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 1.95e-03 | 151 | 34 | 3 | GO:0002832 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.98e-03 | 40 | 34 | 2 | GO:0045953 | |
| MousePheno | abnormal exocrine gland morphology | DNAH2 GHR STARD7 SULT1A2 PAX2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 RPE RPEL1 | 4.87e-08 | 853 | 29 | 12 | MP:0013558 |
| MousePheno | enlarged gallbladder | 2.95e-07 | 28 | 29 | 4 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 5.16e-07 | 32 | 29 | 4 | MP:0020134 | |
| MousePheno | enlarged thymus | 1.70e-06 | 292 | 29 | 7 | MP:0000709 | |
| MousePheno | enlarged spleen | LGALS9C SULT1A2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 LGALS9B RPE RPEL1 | 5.15e-06 | 862 | 29 | 10 | MP:0000691 |
| MousePheno | enlarged lymph nodes | 6.20e-06 | 507 | 29 | 8 | MP:0000702 | |
| MousePheno | abnormal lymph node morphology | DNAH2 LGALS9C SULT1A2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 LGALS9B | 6.24e-06 | 683 | 29 | 9 | MP:0002339 |
| MousePheno | abnormal male accessory sex gland morphology | 6.54e-06 | 358 | 29 | 7 | MP:0013330 | |
| MousePheno | abnormal gallbladder morphology | 6.72e-06 | 60 | 29 | 4 | MP:0005084 | |
| MousePheno | abnormal lymph node size | 1.30e-05 | 561 | 29 | 8 | MP:0000701 | |
| MousePheno | abnormal spleen size | GHR LGALS9C SULT1A2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 LGALS9B RPE RPEL1 | 1.48e-05 | 1203 | 29 | 11 | MP:0002224 |
| MousePheno | visceromegaly | LGALS9C SULT1A2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 LGALS9B RPE RPEL1 | 2.48e-05 | 1030 | 29 | 10 | MP:0013328 |
| MousePheno | abnormal male reproductive gland morphology | DNAH2 GHR SULT1A2 PAX2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 RPE RPEL1 | 2.86e-05 | 1290 | 29 | 11 | MP:0013325 |
| MousePheno | abnormal seminal vesicle morphology | 4.11e-05 | 319 | 29 | 6 | MP:0002059 | |
| MousePheno | lymph node hyperplasia | 4.20e-05 | 33 | 29 | 3 | MP:0008102 | |
| MousePheno | abnormal mammary gland morphology | 5.24e-05 | 201 | 29 | 5 | MP:0000627 | |
| MousePheno | abnormal apocrine gland morphology | 5.24e-05 | 201 | 29 | 5 | MP:0013554 | |
| MousePheno | abnormal internal male genitalia morphology | DNAH2 GHR SULT1A2 PAX2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 RPE RPEL1 | 5.82e-05 | 1392 | 29 | 11 | MP:0009205 |
| MousePheno | abnormal male genitalia morphology | DNAH2 GHR SULT1A2 PAX2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 RPE RPEL1 | 6.78e-05 | 1415 | 29 | 11 | MP:0009198 |
| MousePheno | abnormal male reproductive system morphology | DNAH2 GHR SULT1A2 PAX2 SULT1A4 PTEN SULT1A1 SULT1A3 DACH2 RPE RPEL1 | 6.78e-05 | 1415 | 29 | 11 | MP:0001145 |
| MousePheno | abnormal biliary tract morphology | 9.42e-05 | 117 | 29 | 4 | MP:0005083 | |
| MousePheno | abnormal lymph node B cell domain morphology | 1.00e-04 | 44 | 29 | 3 | MP:0002344 | |
| MousePheno | abnormal thymus size | 1.21e-04 | 564 | 29 | 7 | MP:0002364 | |
| MousePheno | abnormal lymph node cortex morphology | 1.47e-04 | 50 | 29 | 3 | MP:0002343 | |
| MousePheno | abnormal testis morphology | 2.32e-04 | 1081 | 29 | 9 | MP:0001146 | |
| MousePheno | abnormal endocrine gland morphology | GHR LGALS9C SULT1A2 PAX2 SULT1A4 PTEN SULT1A1 SULT1A3 LGALS9B | 3.55e-04 | 1144 | 29 | 9 | MP:0013560 |
| MousePheno | abnormal cochlear nerve morphology | 3.72e-04 | 14 | 29 | 2 | MP:0004716 | |
| MousePheno | abnormal heart size | 4.47e-04 | 1180 | 29 | 9 | MP:0005406 | |
| MousePheno | enlarged uterus | 5.10e-04 | 76 | 29 | 3 | MP:0004906 | |
| MousePheno | abnormal skeletal muscle morphology | 5.20e-04 | 508 | 29 | 6 | MP:0000759 | |
| MousePheno | abnormal thymus morphology | 5.25e-04 | 717 | 29 | 7 | MP:0000703 | |
| MousePheno | enhanced humoral immune response | 5.54e-04 | 17 | 29 | 2 | MP:0020155 | |
| MousePheno | abnormal Peyer's patch morphology | 6.60e-04 | 83 | 29 | 3 | MP:0000696 | |
| MousePheno | increased T-helper 1 cell number | 6.95e-04 | 19 | 29 | 2 | MP:0008086 | |
| MousePheno | abnormal gut-associated lymphoid tissue morphology | 7.07e-04 | 85 | 29 | 3 | MP:0002378 | |
| MousePheno | increased spleen germinal center size | 1.02e-03 | 23 | 29 | 2 | MP:0008483 | |
| MousePheno | abnormal vestibulocochlear nerve morphology | 1.02e-03 | 23 | 29 | 2 | MP:0001072 | |
| MousePheno | abnormal lymph node germinal center morphology | 1.02e-03 | 23 | 29 | 2 | MP:0008522 | |
| MousePheno | abnormal T-helper 1 cell number | 1.11e-03 | 24 | 29 | 2 | MP:0008085 | |
| MousePheno | abnormal lymph node secondary follicle morphology | 1.21e-03 | 25 | 29 | 2 | MP:0002346 | |
| MousePheno | abnormal muscle morphology | 1.43e-03 | 1106 | 29 | 8 | MP:0002108 | |
| MousePheno | abnormal uterus morphology | 1.48e-03 | 415 | 29 | 5 | MP:0001120 | |
| Domain | Sulfotransferase_dom | 4.57e-07 | 36 | 33 | 4 | IPR000863 | |
| Domain | Sulfotransfer_1 | 4.57e-07 | 36 | 33 | 4 | PF00685 | |
| Domain | RIBUL_P_3_EPIMER_1 | 3.03e-06 | 2 | 33 | 2 | PS01085 | |
| Domain | Ribul_P_3_epim | 3.03e-06 | 2 | 33 | 2 | PF00834 | |
| Domain | Ribul_P_3_epim | 3.03e-06 | 2 | 33 | 2 | IPR026019 | |
| Domain | Ribul_P_3_epim-like | 3.03e-06 | 2 | 33 | 2 | IPR000056 | |
| Domain | RibuloseP-bd_barrel | 9.07e-06 | 3 | 33 | 2 | IPR011060 | |
| Domain | Gal-bind_lectin | 3.13e-04 | 15 | 33 | 2 | SM00908 | |
| Domain | GALECTIN | 3.13e-04 | 15 | 33 | 2 | PS51304 | |
| Domain | Galectin_CRD | 3.13e-04 | 15 | 33 | 2 | IPR001079 | |
| Domain | Gal-bind_lectin | 3.13e-04 | 15 | 33 | 2 | PF00337 | |
| Domain | GLECT | 3.13e-04 | 15 | 33 | 2 | SM00276 | |
| Domain | - | 2.49e-03 | 42 | 33 | 2 | 3.20.20.70 | |
| Domain | Aldolase_TIM | 2.73e-03 | 44 | 33 | 2 | IPR013785 | |
| Domain | ConA-like_dom | 6.70e-03 | 219 | 33 | 3 | IPR013320 | |
| Domain | - | 9.41e-03 | 746 | 33 | 5 | 3.40.50.300 | |
| Domain | - | 1.22e-02 | 95 | 33 | 2 | 2.60.120.200 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 5.33e-11 | 5 | 27 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 7.54e-09 | 13 | 27 | 4 | M18256 | |
| Pathway | WP_ESTROGEN_METABOLISM | 7.62e-08 | 22 | 27 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 9.22e-08 | 23 | 27 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 1.10e-07 | 24 | 27 | 4 | M16289 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 8.38e-07 | 39 | 27 | 4 | MM15695 | |
| Pathway | WP_RETINOL_METABOLISM | 1.37e-06 | 44 | 27 | 4 | MM15851 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.62e-06 | 107 | 27 | 5 | MM14595 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.78e-06 | 109 | 27 | 5 | M18788 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 4.19e-06 | 17 | 27 | 3 | M39483 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 1.58e-05 | 26 | 27 | 3 | MM14584 | |
| Pathway | REACTOME_SYNTHESIS_OF_PC | 1.99e-05 | 28 | 27 | 3 | M684 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.21e-05 | 29 | 27 | 3 | M45015 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 5.27e-05 | 6 | 27 | 2 | M39437 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.28e-05 | 219 | 27 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.40e-05 | 220 | 27 | 5 | M10320 | |
| Pathway | REACTOME_DRUG_ADME | 7.29e-05 | 119 | 27 | 4 | MM15692 | |
| Pathway | WP_PENTOSE_PHOSPHATE_PATHWAY | 9.82e-05 | 8 | 27 | 2 | MM15886 | |
| Pathway | WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS | 1.46e-04 | 54 | 27 | 3 | MM15848 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 1.93e-04 | 153 | 27 | 4 | MM15844 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 2.30e-04 | 12 | 27 | 2 | MM14586 | |
| Pathway | REACTOME_SYNTHESIS_OF_PE | 2.72e-04 | 13 | 27 | 2 | M656 | |
| Pathway | WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS | 2.77e-04 | 67 | 27 | 3 | M39710 | |
| Pathway | WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS | 3.17e-04 | 14 | 27 | 2 | M39620 | |
| Pathway | WP_KENNEDY_PATHWAY | 3.17e-04 | 14 | 27 | 2 | MM15980 | |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 3.65e-04 | 15 | 27 | 2 | M27682 | |
| Pathway | REACTOME_PENTOSE_PHOSPHATE_PATHWAY | 3.65e-04 | 15 | 27 | 2 | MM15404 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 4.95e-04 | 196 | 27 | 4 | MM14591 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 6.53e-04 | 211 | 27 | 4 | M649 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 8.72e-04 | 23 | 27 | 2 | MM1470 | |
| Pathway | BIOCARTA_EIF4_PATHWAY | 9.50e-04 | 24 | 27 | 2 | M4791 | |
| Pathway | REACTOME_DRUG_ADME | 1.15e-03 | 109 | 27 | 3 | M45012 | |
| Pathway | KEGG_PENTOSE_PHOSPHATE_PATHWAY | 1.20e-03 | 27 | 27 | 2 | M1386 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.29e-03 | 28 | 27 | 2 | M19580 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 1.52e-03 | 120 | 27 | 3 | MM14585 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 1.69e-03 | 32 | 27 | 2 | MM15290 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 1.82e-03 | 128 | 27 | 3 | M706 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 2.51e-03 | 39 | 27 | 2 | M27579 | |
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 5.17e-13 | 12 | 34 | 5 | 7706460 | |
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 24318996 | ||
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 8424956 | ||
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 33414449 | ||
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 8943792 | ||
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 7.61e-13 | 4 | 34 | 4 | 12390022 | |
| Pubmed | 7.61e-13 | 4 | 34 | 4 | 25370010 | ||
| Pubmed | 3.80e-12 | 5 | 34 | 4 | 11389699 | ||
| Pubmed | 3.80e-12 | 5 | 34 | 4 | 29908303 | ||
| Pubmed | 3.80e-12 | 5 | 34 | 4 | 24802129 | ||
| Pubmed | 3.80e-12 | 5 | 34 | 4 | 25053625 | ||
| Pubmed | 1.32e-11 | 21 | 34 | 5 | 32301970 | ||
| Pubmed | 2.66e-11 | 7 | 34 | 4 | 12438748 | ||
| Pubmed | 2.66e-11 | 7 | 34 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 5.31e-11 | 8 | 34 | 4 | 10594240 | |
| Pubmed | 9.55e-11 | 9 | 34 | 4 | 9166597 | ||
| Pubmed | 9.55e-11 | 9 | 34 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 9.55e-11 | 9 | 34 | 4 | 23207770 | |
| Pubmed | 9.55e-11 | 9 | 34 | 4 | 8468045 | ||
| Pubmed | 9.55e-11 | 9 | 34 | 4 | 19548878 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 9.55e-11 | 9 | 34 | 4 | 9060415 | |
| Pubmed | 9.55e-11 | 9 | 34 | 4 | 9177785 | ||
| Pubmed | 1.59e-10 | 10 | 34 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 2.50e-10 | 11 | 34 | 4 | 7613026 | |
| Pubmed | 2.50e-10 | 11 | 34 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.50e-10 | 11 | 34 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 2.50e-10 | 11 | 34 | 4 | 9034160 | |
| Pubmed | 2.50e-10 | 11 | 34 | 4 | 10720750 | ||
| Pubmed | 5.41e-10 | 13 | 34 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 5.41e-10 | 13 | 34 | 4 | 17425406 | |
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 8.54e-10 | 3 | 34 | 3 | 8363592 | |
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 9855620 | ||
| Pubmed | 8.54e-10 | 3 | 34 | 3 | 8912648 | ||
| Pubmed | 1.03e-09 | 15 | 34 | 4 | 1741163 | ||
| Pubmed | 2.31e-09 | 18 | 34 | 4 | 20056724 | ||
| Pubmed | 3.41e-09 | 4 | 34 | 3 | 32152050 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 1.02e-07 | 10 | 34 | 3 | 11535246 | |
| Pubmed | 5.75e-07 | 17 | 34 | 3 | 9196007 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 7.47e-07 | 72 | 34 | 4 | 8075499 | |
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 9.28e-07 | 2 | 34 | 2 | 14871892 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20026284 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 35578896 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11964179 | ||
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 9.28e-07 | 2 | 34 | 2 | 23358261 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 19915674 | ||
| Pubmed | Structure and function of choline kinase isoforms in mammalian cells. | 9.28e-07 | 2 | 34 | 2 | 15003397 | |
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 9.28e-07 | 2 | 34 | 2 | 38069221 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 11207031 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12761191 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 9.28e-07 | 2 | 34 | 2 | 20936502 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 33828085 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10543947 | ||
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 9.28e-07 | 2 | 34 | 2 | 7581483 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29705271 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 15752422 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 29590317 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20417180 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16490392 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 9.28e-07 | 2 | 34 | 2 | 10762004 | |
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 9.28e-07 | 2 | 34 | 2 | 8117269 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9566757 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 8093002 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 12469224 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 31145702 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 10617600 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 16133548 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 8033246 | ||
| Pubmed | Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. | 9.28e-07 | 2 | 34 | 2 | 20631067 | |
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 9714798 | ||
| Pubmed | 9.28e-07 | 2 | 34 | 2 | 20299452 | ||
| Pubmed | Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis. | 2.78e-06 | 3 | 34 | 2 | 29458010 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 19776007 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 26582205 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 7695643 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 9153289 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 33316546 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 18974023 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 9038233 | ||
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 2.78e-06 | 3 | 34 | 2 | 26067475 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23144904 | ||
| Pubmed | Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings. | 2.78e-06 | 3 | 34 | 2 | 29651447 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 28704475 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 21146220 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23836896 | ||
| Pubmed | Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes. | 2.78e-06 | 3 | 34 | 2 | 7890611 | |
| Pubmed | Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. | 2.78e-06 | 3 | 34 | 2 | 22341088 | |
| Pubmed | Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9. | 2.78e-06 | 3 | 34 | 2 | 28990062 | |
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 32380082 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23667648 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 18579572 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 18259693 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 28877989 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 19800850 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 38987795 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 16990264 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 18005988 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 23585851 | ||
| Pubmed | 2.78e-06 | 3 | 34 | 2 | 24477688 | ||
| Pubmed | A unique role for galectin-9 in angiogenesis and inflammatory arthritis. | 2.78e-06 | 3 | 34 | 2 | 29433546 | |
| Interaction | SULT1C2 interactions | 2.57e-08 | 19 | 34 | 4 | int:SULT1C2 | |
| Interaction | SULT1A3 interactions | 7.00e-08 | 24 | 34 | 4 | int:SULT1A3 | |
| Interaction | SULT1A4 interactions | 1.58e-06 | 14 | 34 | 3 | int:SULT1A4 | |
| Interaction | SULT1A2 interactions | 4.17e-06 | 19 | 34 | 3 | int:SULT1A2 | |
| Interaction | SULT1A1 interactions | 4.80e-06 | 67 | 34 | 4 | int:SULT1A1 | |
| Interaction | SULT4A1 interactions | 8.67e-06 | 24 | 34 | 3 | int:SULT4A1 | |
| Interaction | SULT1B1 interactions | 7.69e-05 | 8 | 34 | 2 | int:SULT1B1 | |
| Interaction | SULT2B1 interactions | 1.48e-04 | 61 | 34 | 3 | int:SULT2B1 | |
| Interaction | SULT1C3 interactions | 1.51e-04 | 11 | 34 | 2 | int:SULT1C3 | |
| Interaction | SULT2A1 interactions | 1.51e-04 | 11 | 34 | 2 | int:SULT2A1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 5.29e-05 | 278 | 34 | 4 | chr16p11 | |
| Cytoband | 16p12.1 | 1.58e-04 | 25 | 34 | 2 | 16p12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q24 | 3.74e-04 | 189 | 34 | 3 | chr10q24 | |
| Cytoband | 17p11.2 | 6.22e-03 | 159 | 34 | 2 | 17p11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q25 | 7.90e-03 | 180 | 34 | 2 | chr3q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p11 | 9.95e-03 | 203 | 34 | 2 | chr17p11 | |
| GeneFamily | Sulfotransferases, cytosolic | 1.63e-09 | 14 | 22 | 4 | 762 | |
| GeneFamily | Galectins | 1.47e-04 | 15 | 22 | 2 | 629 | |
| GeneFamily | Fibronectin type III domain containing | 1.60e-02 | 160 | 22 | 2 | 555 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 5.65e-10 | 75 | 34 | 6 | MM1084 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 5.21e-09 | 108 | 34 | 6 | MM1334 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_DN | 1.99e-08 | 135 | 34 | 6 | MM753 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.46e-08 | 24 | 34 | 4 | MM1317 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 4.91e-08 | 157 | 34 | 6 | MM1099 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 1.81e-06 | 68 | 34 | 4 | MM770 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 4.23e-06 | 84 | 34 | 4 | MM873 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 1.12e-05 | 399 | 34 | 6 | M40939 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.12e-05 | 399 | 34 | 6 | M41172 | |
| Coexpression | LE_EGR2_TARGETS_DN | 1.58e-05 | 117 | 34 | 4 | MM1139 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 1.63e-05 | 5 | 34 | 2 | M41007 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 3.61e-05 | 491 | 34 | 6 | MM455 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_HEPATOCYTE_AGEING | 3.86e-05 | 147 | 34 | 4 | MM3753 | |
| Coexpression | INGRAM_SHH_TARGETS_UP | 4.87e-05 | 156 | 34 | 4 | MM550 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 5.51e-05 | 161 | 34 | 4 | M11857 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | 6.25e-05 | 542 | 34 | 6 | M19529 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 1.12e-04 | 72 | 34 | 3 | M9908 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | 1.26e-04 | 382 | 34 | 5 | M38972 | |
| Coexpression | GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP | 1.28e-04 | 200 | 34 | 4 | M4458 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | 1.65e-04 | 647 | 34 | 6 | MM981 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 2.39e-04 | 93 | 34 | 3 | MM1137 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_DN | 2.53e-04 | 444 | 34 | 5 | MM1051 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_STEM_CELL_AGEING | 2.96e-04 | 721 | 34 | 6 | MM3800 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 2.96e-04 | 721 | 34 | 6 | M10237 | |
| Coexpression | DESCARTES_ORGANOGENESIS_OSTEOBLASTS | 3.71e-04 | 22 | 34 | 2 | MM3653 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#4_top-relative-expression-ranked_500 | 9.07e-05 | 58 | 32 | 3 | gudmap_developingGonad_e14.5_ ovary_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 1.28e-04 | 776 | 32 | 7 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 1.30e-04 | 778 | 32 | 7 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.43e-04 | 178 | 32 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 1.73e-04 | 72 | 32 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.14e-05 | 184 | 34 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.58e-05 | 200 | 34 | 4 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 176 | 34 | 3 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 176 | 34 | 3 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 176 | 34 | 3 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 176 | 34 | 3 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 176 | 34 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | NS-moderate-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.27e-04 | 177 | 34 | 3 | 174c54acfe19e2bb31418d69e228032ba724cbb6 | |
| ToppCell | ASK428-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.27e-04 | 177 | 34 | 3 | 66074a288501c136b4e83b883db5f0d8269ee326 | |
| ToppCell | Mid-temporal_gyrus_(MTG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.33e-04 | 178 | 34 | 3 | ad187db4c40b9078d54dd915c143e0172b2f47b8 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-04 | 181 | 34 | 3 | 6d1f1ad35778a2a227f966f11f6edd8e89452576 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 3.61e-04 | 183 | 34 | 3 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.73e-04 | 185 | 34 | 3 | 7b3d30a54bec66ca6b0209c86448f4fff97ed75c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.79e-04 | 186 | 34 | 3 | 10edc3dd96181b6f7bd07a5ad0862ba9fa6a9cb9 | |
| ToppCell | (2)_5-FU-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(2)_5-FU / Stress and Cell class | 3.85e-04 | 187 | 34 | 3 | 6bbf0f7fe203274dae8d582652f35cd3187c0065 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.91e-04 | 188 | 34 | 3 | 2e268d8091e25d50bf05f26517d3ceb583801fd4 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.91e-04 | 188 | 34 | 3 | 59d5c7b147af118442adadf708ce2d1422b1e9aa | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 189 | 34 | 3 | 45b9d00a4968fb22207d95228cdcf022afe1e50b | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 189 | 34 | 3 | 8382d331e01e83591ba9c8ea83edbf2436c18b17 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-04 | 189 | 34 | 3 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 190 | 34 | 3 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-04 | 190 | 34 | 3 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.03e-04 | 190 | 34 | 3 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-04 | 191 | 34 | 3 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.09e-04 | 191 | 34 | 3 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-04 | 191 | 34 | 3 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-04 | 191 | 34 | 3 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-04 | 191 | 34 | 3 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-04 | 191 | 34 | 3 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | (1)_Control_(PBS)|World / Stress and Cell class | 4.09e-04 | 191 | 34 | 3 | b346e13259cb2d506b923ad44b894c21a3eee4c3 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.09e-04 | 191 | 34 | 3 | 2ad717b59215ad8d933e9637d363b65d7298e5d4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-04 | 191 | 34 | 3 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 192 | 34 | 3 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 4.15e-04 | 192 | 34 | 3 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 192 | 34 | 3 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.22e-04 | 193 | 34 | 3 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-04 | 194 | 34 | 3 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.28e-04 | 194 | 34 | 3 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-NK-Cycling_NK|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.28e-04 | 194 | 34 | 3 | af08047e5728ee8198d2686af6a774f2acfa58ba | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-04 | 194 | 34 | 3 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-04 | 195 | 34 | 3 | b9e8f405f6d837bb39b615836d3e2df349737c0e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | wk_08-11-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.35e-04 | 195 | 34 | 3 | c0ea25ed1a849e6efff885e98013a4f1d5134758 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.35e-04 | 195 | 34 | 3 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | (2)_5-FU|World / Stress and Cell class | 4.35e-04 | 195 | 34 | 3 | e5b1d96fafeb2f3b1f4cdf6b2c9eddef36bca7ff | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-04 | 195 | 34 | 3 | 6c9c58322c1df891bb4bab56dacb542c8777bb7d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-04 | 195 | 34 | 3 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.35e-04 | 195 | 34 | 3 | dfc5da514fb34a2c318a5c4c61f44049fa43960e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 196 | 34 | 3 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 196 | 34 | 3 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 196 | 34 | 3 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 196 | 34 | 3 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-04 | 196 | 34 | 3 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|(2)_5-FU / Stress and Cell class | 4.41e-04 | 196 | 34 | 3 | cc0a172de71d9a1a882c9e78652dae70e007d012 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-04 | 196 | 34 | 3 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-04 | 197 | 34 | 3 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | 4.48e-04 | 197 | 34 | 3 | 1dd980fd066aef21694395a4b69df938501d9631 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-E|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.48e-04 | 197 | 34 | 3 | 9b1c1d72c5a8c90d71ae31e4c198d2276872eaa0 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.48e-04 | 197 | 34 | 3 | 9b3d6fe76dd7d61a286a28d9466b5f2fece048e1 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.48e-04 | 197 | 34 | 3 | 9c8c1ce8ed69b3c2b12ecca349ac1901f66b46ab | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-04 | 197 | 34 | 3 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | (2)_5-FU-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 4.48e-04 | 197 | 34 | 3 | 434ae0231972acba12d06279908cf407e70511ac | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Late_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.48e-04 | 197 | 34 | 3 | 797ea1c9f75f88b51fdfc17a2b27ed0199ae64c9 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.48e-04 | 197 | 34 | 3 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.48e-04 | 197 | 34 | 3 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.54e-04 | 198 | 34 | 3 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.54e-04 | 198 | 34 | 3 | f3346c26b9647a199faf3cd7ab19c3a963dbabc2 | |
| ToppCell | mLN-T_cell-Th17|T_cell / Region, Cell class and subclass | 4.54e-04 | 198 | 34 | 3 | efdc9515dd9fb20ef9c8ddc106d88cbdde7d6ea2 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.54e-04 | 198 | 34 | 3 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-E_(AT2)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.54e-04 | 198 | 34 | 3 | 498f11441c0a0982738537bcfcfc2877866b7400 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-04 | 198 | 34 | 3 | 85215015bb86ada0e871c413a4ecdc903a3785ca | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-04 | 198 | 34 | 3 | 2967fb2d94662997bfe932ac299c80d6f182fb48 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.54e-04 | 198 | 34 | 3 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-04 | 198 | 34 | 3 | 8fac96132663f54566136ef54b53684d31dfde32 | |
| ToppCell | C_01|World / shred on cell type and cluster | 4.54e-04 | 198 | 34 | 3 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-mature_enterocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-04 | 198 | 34 | 3 | 222a060c2c63d30da34e4b71c37aa27a048d7d09 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.54e-04 | 198 | 34 | 3 | c48b3f026b16d48b8eca9f74dc1e3f3f39a89322 | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 4.54e-04 | 198 | 34 | 3 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-04 | 198 | 34 | 3 | 38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.54e-04 | 198 | 34 | 3 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 4.61e-04 | 199 | 34 | 3 | ea1e2ccde3930fab6d04a9bf130837455c742474 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|COVID-19_Severe / Disease condition and Cell class | 4.61e-04 | 199 | 34 | 3 | ffb2ef9b7006cbed0f43637af040719b9776cbd5 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-04 | 200 | 34 | 3 | 4984d27b3768be3b8fca3391cd2b7ab1749e2913 | |
| ToppCell | mLN-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 4.68e-04 | 200 | 34 | 3 | e3c15e0e1c2602b0cc9ab8cc50c978d265350c94 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-04 | 200 | 34 | 3 | f65837b51bce94c08125b1a2e1a696a15267f64b | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-04 | 200 | 34 | 3 | 527b7388700096686293f3f6b112269e87908dfa | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 4.68e-04 | 200 | 34 | 3 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Grm5_(CA1_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.14e-04 | 44 | 34 | 2 | 598044d7c325bc48ac8ab0c0722b4bb263028d71 | |
| Drug | luciferyl sulfate | 1.28e-10 | 7 | 33 | 4 | CID011953812 | |
| Drug | dopamine-4-O-sulfate | 1.28e-10 | 7 | 33 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 1.28e-10 | 7 | 33 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 1.28e-10 | 7 | 33 | 4 | CID003035977 | |
| Drug | 2-iodophenol | 2.55e-10 | 8 | 33 | 4 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 2.55e-10 | 8 | 33 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 2.55e-10 | 8 | 33 | 4 | CID003037707 | |
| Drug | EM-139 | 2.59e-09 | 13 | 33 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 3.62e-09 | 14 | 33 | 4 | CID000020908 | |
| Drug | deoxoestrone | 3.62e-09 | 14 | 33 | 4 | CID000005888 | |
| Drug | arylsulfate | 4.93e-09 | 15 | 33 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 4.93e-09 | 15 | 33 | 4 | CID000002895 | |
| Drug | A-44 | 6.57e-09 | 16 | 33 | 4 | CID000120353 | |
| Drug | benzilic acid | 8.59e-09 | 17 | 33 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 1.40e-08 | 19 | 33 | 4 | CID000115063 | |
| Drug | pedunculagin | 1.40e-08 | 19 | 33 | 4 | CID000442688 | |
| Drug | PLP-Glu | 1.74e-08 | 20 | 33 | 4 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 2.15e-08 | 21 | 33 | 4 | CID000005895 | |
| Drug | MeA alpha C | 2.63e-08 | 22 | 33 | 4 | CID000062244 | |
| Drug | AABSSN | 2.63e-08 | 22 | 33 | 4 | CID005464134 | |
| Drug | taselin | 3.17e-08 | 23 | 33 | 4 | CID000023846 | |
| Drug | AalphaC | 3.81e-08 | 24 | 33 | 4 | CID000062805 | |
| Drug | minoxidil sulphate | 4.53e-08 | 25 | 33 | 4 | CID000004202 | |
| Drug | 2-pentanone | 4.53e-08 | 25 | 33 | 4 | CID000007895 | |
| Drug | AzMC | 4.53e-08 | 25 | 33 | 4 | CID000064986 | |
| Drug | alpha-methyldopamine | 5.34e-08 | 26 | 33 | 4 | CID000017005 | |
| Drug | glycolithocholic acid | 5.34e-08 | 26 | 33 | 4 | CID000115245 | |
| Drug | 1m2q | 5.34e-08 | 26 | 33 | 4 | CID005326637 | |
| Drug | Glu-P-2 | 8.46e-08 | 29 | 33 | 4 | CID000049970 | |
| Drug | Phosphoadenosine Phosphosulfate | 9.67e-08 | 7 | 33 | 3 | ctd:D010724 | |
| Drug | 3,3'-T2 | 9.76e-08 | 30 | 33 | 4 | CID000065559 | |
| Drug | A2'p5'A2'p5'A | 1.12e-07 | 31 | 33 | 4 | CID000122642 | |
| Drug | barium hydroxide | 1.12e-07 | 31 | 33 | 4 | CID000028387 | |
| Drug | acetaminophen sulfate | 1.12e-07 | 31 | 33 | 4 | CID000083939 | |
| Drug | reverse T3 | 1.17e-07 | 82 | 33 | 5 | CID000022069 | |
| Drug | DCNP | 1.45e-07 | 33 | 33 | 4 | CID000012066 | |
| Drug | N-hydroxy-4-aminobiphenyl | 1.55e-07 | 8 | 33 | 3 | ctd:C014593 | |
| Drug | mefenamic acid | 2.33e-07 | 37 | 33 | 4 | CID000004044 | |
| Drug | phenylhydroxylamine | 2.61e-07 | 38 | 33 | 4 | CID000007518 | |
| Drug | 1 C2 | 3.18e-07 | 100 | 33 | 5 | CID005327152 | |
| Drug | d-equilenin | 3.56e-07 | 41 | 33 | 4 | CID000010597 | |
| Drug | L-alpha-methyldopa | 3.94e-07 | 42 | 33 | 4 | CID000004138 | |
| Drug | Woodward's reagent K | 4.34e-07 | 43 | 33 | 4 | CID000077804 | |
| Drug | NSC674039 | 4.76e-07 | 44 | 33 | 4 | CID000001249 | |
| Drug | 1IIg | 5.22e-07 | 45 | 33 | 4 | CID000001682 | |
| Drug | NDPS | 5.22e-07 | 45 | 33 | 4 | CID000090363 | |
| Drug | 4-octylphenol | 6.24e-07 | 47 | 33 | 4 | CID000015730 | |
| Drug | sulfamethazine | 6.80e-07 | 48 | 33 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 6.80e-07 | 48 | 33 | 4 | CID000005896 | |
| Drug | salicylamide | 6.80e-07 | 48 | 33 | 4 | CID000005147 | |
| Drug | 9-hydroxybenzo(a)pyrene | 1.02e-06 | 53 | 33 | 4 | CID000028598 | |
| Drug | minoxidil | 1.10e-06 | 54 | 33 | 4 | CID000004201 | |
| Drug | androstenediol | 1.10e-06 | 54 | 33 | 4 | CID000010634 | |
| Drug | MeIQx | 1.18e-06 | 55 | 33 | 4 | CID000062275 | |
| Drug | NSC36919 | 1.47e-06 | 58 | 33 | 4 | CID000235496 | |
| Drug | 4-hydroxyestrone | 1.57e-06 | 59 | 33 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.57e-06 | 59 | 33 | 4 | CID000083944 | |
| Drug | 5-hydroxymethylfurfural | 2.04e-06 | 2 | 33 | 2 | ctd:C008046 | |
| Drug | 6-hydroxymelatonin | 2.04e-06 | 2 | 33 | 2 | ctd:C012365 | |
| Drug | Hydroxytryptophol | 2.04e-06 | 2 | 33 | 2 | ctd:D006917 | |
| Drug | 3-OHBaP | 2.05e-06 | 63 | 33 | 4 | CID000025890 | |
| Drug | 4-nonylphenol | 2.18e-06 | 64 | 33 | 4 | CID000001752 | |
| Drug | epicatechin-3-gallate | 2.33e-06 | 65 | 33 | 4 | CID000065056 | |
| Drug | Pyrethroids | 3.32e-06 | 71 | 33 | 4 | CID000005053 | |
| Drug | adenylylsulfate | 3.51e-06 | 72 | 33 | 4 | CID000000228 | |
| Drug | 7-hydroxycoumarin | 4.13e-06 | 75 | 33 | 4 | CID005281426 | |
| Drug | benzyloxyresorufin | 4.84e-06 | 78 | 33 | 4 | CID000114982 | |
| Drug | 4-hydroxyestradiol | 5.09e-06 | 79 | 33 | 4 | CID000001743 | |
| Drug | 5-hydroxyindole | 6.11e-06 | 3 | 33 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 6.11e-06 | 3 | 33 | 2 | ctd:D008914 | |
| Drug | 5-hydroxy-3-methylindole | 6.11e-06 | 3 | 33 | 2 | CID000192734 | |
| Drug | 8-azaadenine | 6.11e-06 | 3 | 33 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 6.11e-06 | 3 | 33 | 2 | ctd:C030629 | |
| Drug | P2-N | 6.24e-06 | 25 | 33 | 3 | CID011987828 | |
| Drug | 4-aminobiphenyl | 9.34e-06 | 92 | 33 | 4 | CID000007102 | |
| Drug | p-nitroanisole | 9.34e-06 | 92 | 33 | 4 | CID000007485 | |
| Drug | 2-naphthol | 9.75e-06 | 93 | 33 | 4 | CID000008663 | |
| Drug | 1-naphthol | 1.20e-05 | 98 | 33 | 4 | CID000007005 | |
| Drug | adenosine 3'-5'-diphosphate | 1.20e-05 | 98 | 33 | 4 | CID000000073 | |
| Drug | Chebi:32701 | 1.22e-05 | 4 | 33 | 2 | CID005460855 | |
| Drug | A21250 | 1.58e-05 | 105 | 33 | 4 | CID000000990 | |
| Drug | 2-naphthylamine | 1.89e-05 | 110 | 33 | 4 | CID000007057 | |
| Drug | pinocembrin | 2.03e-05 | 5 | 33 | 2 | ctd:C016063 | |
| Drug | TKPP | 2.03e-05 | 5 | 33 | 2 | CID000023740 | |
| Drug | harmol | 2.03e-05 | 5 | 33 | 2 | ctd:C001326 | |
| Drug | gallic acid | 2.34e-05 | 116 | 33 | 4 | CID000000370 | |
| Drug | pentachlorophenol | 2.67e-05 | 120 | 33 | 4 | CID000000992 | |
| Drug | phenylglyoxal | 2.76e-05 | 121 | 33 | 4 | CID000014090 | |
| Drug | PhIP-HCl | 2.94e-05 | 123 | 33 | 4 | CID000001530 | |
| Drug | 2-Sulfotrehalose | 3.04e-05 | 6 | 33 | 2 | CID000124677 | |
| Drug | N-hydroxy-2-acetylaminophenanthrene | 3.04e-05 | 6 | 33 | 2 | CID000017102 | |
| Drug | tyramine | 3.65e-05 | 130 | 33 | 4 | CID000005610 | |
| Drug | AC1L577W | 4.26e-05 | 7 | 33 | 2 | CID000171279 | |
| Drug | N-acetyl-2-naphthylhydroxylamine | 4.26e-05 | 7 | 33 | 2 | CID000017272 | |
| Drug | catechol | 4.59e-05 | 48 | 33 | 3 | ctd:C034221 | |
| Drug | aniline | 5.16e-05 | 142 | 33 | 4 | CID000006115 | |
| Drug | 6-hydroxymelatonin | 5.19e-05 | 50 | 33 | 3 | CID000001864 | |
| Drug | 1-hydroxypyrene | 5.51e-05 | 51 | 33 | 3 | ctd:C033146 | |
| Drug | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine | 5.67e-05 | 8 | 33 | 2 | ctd:C077584 | |
| Drug | 3-hydroxy-3-methyloxindole | 7.29e-05 | 9 | 33 | 2 | CID000151066 | |
| Disease | brain disease (implicated_via_orthology) | 1.30e-05 | 6 | 28 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | urinary bladder cancer (is_implicated_in) | 5.14e-05 | 76 | 28 | 3 | DOID:11054 (is_implicated_in) | |
| Disease | X-12707 measurement | 5.70e-05 | 12 | 28 | 2 | EFO_0800720 | |
| Disease | ascorbic acid 3-sulfate measurement | 7.85e-05 | 14 | 28 | 2 | EFO_0800173 | |
| Disease | Autosome Abnormalities | 1.03e-04 | 16 | 28 | 2 | C0004403 | |
| Disease | Chromosome Aberrations | 1.03e-04 | 16 | 28 | 2 | C0008625 | |
| Disease | microcephaly (implicated_via_orthology) | 4.23e-04 | 32 | 28 | 2 | DOID:10907 (implicated_via_orthology) | |
| Disease | Lymphoma | 6.62e-04 | 40 | 28 | 2 | C0024299 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 8.38e-04 | 45 | 28 | 2 | DOID:3748 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FKMPEMHFKAPKISM | 1311 | Q09666 | |
| FKMPEMHFKAPKISM | 1641 | Q09666 | |
| FKMPDMHFKAPNISM | 2441 | Q09666 | |
| ALDMDAIKKMAMSHG | 986 | Q96PN6 | |
| AIATKMAQFHGMEMP | 166 | Q9Y259 | |
| VDMHGMKVASFLMDG | 71 | Q96NX9 | |
| DSMLGAMFSGKMPTK | 26 | Q4G0X4 | |
| ERKMHMPFQKGMPFD | 86 | Q6DKI2 | |
| ERKMHMPFQKGMPFD | 86 | Q3B8N2 | |
| MDMHCKADPFSAMHP | 1 | Q02962 | |
| MMHLGYEKMAKATGK | 1046 | Q14008 | |
| KNKAGMSQCDMHPEM | 506 | P10912 | |
| AEIAEKMATFHGMKM | 226 | P35790 | |
| KMATFHGMKMPFNKE | 231 | P35790 | |
| HKDGIDLAGFKMMEM | 1221 | Q05707 | |
| FMDDLNMPAKDMFGS | 2481 | Q9P225 | |
| HKMMFETIPMFSGGT | 196 | P60484 | |
| SMMGGKDFVVRHFKM | 71 | Q9UGT4 | |
| HSDKMKMLGPFTMGI | 121 | Q86VY9 | |
| AEAKMALAMAKPMAK | 366 | P0DPB3 | |
| HMVPSDQGDMALKMM | 431 | Q9HB40 | |
| PSMMAKHLKDFAMDG | 301 | Q99707 | |
| EKDEKSMMCPPGMHK | 746 | O75592 | |
| ELMDHSISPFMRKGM | 246 | P0DMN0 | |
| ELMDHSISPFMRKGM | 246 | P0DMM9 | |
| LAAKMAALASMAHGM | 1471 | Q9NRC6 | |
| MQKMAKSHVFLSGMG | 56 | A0AVT1 | |
| DRECNDMMAHKMKEP | 116 | Q5GAN6 | |
| LGQDPFFDMHMMVSK | 61 | Q2QD12 | |
| EFMDHSISPFMRKGM | 246 | P50225 | |
| EFMDHSISPFMRKGM | 246 | P50226 | |
| MAAPMAGLMEKAGKD | 791 | Q9C0C9 | |
| AMMKPKGQTEHDEGM | 236 | Q9NTJ3 | |
| NATFMGFKMMDGKQH | 441 | Q6AHZ1 | |
| SIMKKTMGMADGKHC | 926 | Q96JH7 | |
| MVSSGMPDFLEKLHM | 306 | Q9NQZ5 | |
| LGQDPFFDMHMMVSK | 61 | Q96AT9 |